Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00412035
Status:
COMPLETED
Last Update Posted:
2014-12-23
First Post:
2006-12-13
Brief Title:
Botox Injection for Lower Extremity Lengthening and Deformity Correction Surgery
Sponsor:
Shriners Hospitals for Children
Organization:
Shriners Hospitals for Children
Study Overview
Official Title:
Safety and Efficacy of Botox Injection in Alleviating Post-Operative Pain and Improving Quality of Life in Lower Extremity Limb Lengthening and Deformity Correction
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
BOLLD
Brief Summary:
The purpose of this six site multi-center study is to determine if BTX-A can alleviate the post-operative pain and improve the functional and quality of life outcomes of children with limb length discrepancy or angular deformity undergoing limb lengthening or deformity correction
Detailed Description:
The specific aims are to determine if BTX-A will
1a Reduce pain post operatively and during the distraction and consolidation process
1b Reduce the amount frequency and duration of narcotics taken in the postoperative period
2 Improve the quality of life during the distraction and consolidation process
3 Decrease muscular spasm and subsequent muscle contracture during the distraction and consolidation process and accelerate earlier return to pre-operative mobility function including earlier weight bearing
4 To develop clinical practice guidelines for the interdisciplinary care of children undergoing limb lengthening or deformity correction
Methodology A randomization process for this one time injection will be used to determine who will receive the BTX-A or the placebo 150 subjects will be recruited 75 to the BTX-A group and 75 to the placebo group There will be an equal number of subjects in each group at each site The medication will be injected intraoperatively into specific major muscles in the lower limb adjacent to the bone or soft tissue being lengthened or corrected at a dose of 10 Ukg with a maximum of 50 U per site not to exceed a total maximum dose of 400 units Pain scores medication dosages range of motion and an ambulation scale will be measured post-operatively and during the distraction and consolidation phases
In addition families will be asked to complete six different questionnaires related to pain quality of life and psycho-social issues at various times during the process The children will receive standard nursing care and physical therapy and will be followed for three months after the external fixator is removed for a total time of approximately one year
1a Reduce pain post operatively and during the distraction and consolidation process
1b Reduce the amount frequency and duration of narcotics taken in the postoperative period
2 Improve the quality of life during the distraction and consolidation process
3 Decrease muscular spasm and subsequent muscle contracture during the distraction and consolidation process and accelerate earlier return to pre-operative mobility function including earlier weight bearing
4 To develop clinical practice guidelines for the interdisciplinary care of children undergoing limb lengthening or deformity correction
Methodology A randomization process for this one time injection will be used to determine who will receive the BTX-A or the placebo 150 subjects will be recruited 75 to the BTX-A group and 75 to the placebo group There will be an equal number of subjects in each group at each site The medication will be injected intraoperatively into specific major muscles in the lower limb adjacent to the bone or soft tissue being lengthened or corrected at a dose of 10 Ukg with a maximum of 50 U per site not to exceed a total maximum dose of 400 units Pain scores medication dosages range of motion and an ambulation scale will be measured post-operatively and during the distraction and consolidation phases
In addition families will be asked to complete six different questionnaires related to pain quality of life and psycho-social issues at various times during the process The children will receive standard nursing care and physical therapy and will be followed for three months after the external fixator is removed for a total time of approximately one year
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None